UNSPSC 51112403: Dacarbazine citrate

This classification denotes a triazene compound with the molecular formula C6H10N6O.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9UYU348NIF. European Medicines Agency schedules dacarbazine citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01547MIG. As of Q4 2014, DACARBAZINE CITRATE remains US FDA's Preferred Term for this commodity. Most nations, for tariff and trade purposes, schedule dacarbazine citrate under HS 29332990 and SITC 51573.

SMILES: CN(C)/N=N/C1C(NC[NH]1)C(=O)N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.

UNSPSC 51112403 Dacarbazine citrate is a Commodity code that designates a specific chemotherapy drug used in cancer treatment; state and local procurement activity under it centers on pharmaceutical sourcing and supply chain arrangements for health plans and employee benefits programs serving public sector populations. The code captures acquisitions of this and related oncologic pharmaceutical products by state health agencies, typically through pharmacy benefit managers, group purchasing organizations, or direct manufacturer relationships structured to optimize cost and fulfillment efficiency for self-insured plans and state employee health programs.

State health and human services departments are the primary issuing bodies under this code. Texas Health and Human Services Commission has recently issued exploratory solicitations to gather vendor capabilities on direct-to-manufacturer prescription programs, moving away from traditional PBM and GPO intermediaries. The April 2026 Request for Information (RFI) HHS0017013 from Texas HHS sought vendor input on establishing direct relationships between the state's pharmacy benefit program and manufacturers to improve prescription fulfillment and cost management; the RFI focused on vendors' experience with direct contracting for self-insured employers and health plans in government sectors, flexibility to negotiate net pricing models without rebates, and capacity to implement value-based or outcomes-based agreements. The RFI functioned as preliminary market intelligence rather than a formal competitive solicitation, designed to inform the state's future procurement strategy before issuing formal RFPs with established financial and temporal parameters. Geographic activity is concentrated in Texas; the source does not identify similar recent activity in other states or jurisdictions.